Mechanisms involved in the antinociception induced by systemic administration of guanosine in mice

British Journal of Pharmacology

Volumn 159, Issue 6, 2010, Pages 1247-1263

  Schmidt, A P ^a,b   Bohmer A E ^a   Schallenberger, C ^a   Antunes, C ^a   Tavares, R G ^c   Wofchuk, S T ^a   Elisabetsky, E ^a   Souza, D O ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c UNIVERSIDADE FEEVALE   (Brazil)

Author keywords

Adenosine; Antinociception; Glutamate; Guanosine; Pain; Purines

Indexed keywords

ACETIC ACID; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; ASPARTATE AMINOTRANSFERASE; CAPSAICIN; DEXAMETHASONE; FORMALDEHYDE; GLUTAMIC ACID; GUANOSINE; KAINIC ACID; MORPHINE; N METHYL DEXTRO ASPARTIC ACID; SUBSTANCE P;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BITE; CEREBROSPINAL FLUID LEVEL; CONTROLLED STUDY; DRUG CEREBROSPINAL FLUID LEVEL; DRUG EFFECT; DRUG MECHANISM; EXPERIMENTAL MODEL; MALE; MOUSE; NONHUMAN; PAIN; PAW EDEMA; PRIORITY JOURNAL; SPINAL CORD; TAIL FLICK TEST;

ADMINISTRATION, ORAL; ANALGESICS; ANIMALS; BEHAVIOR, ANIMAL; CEREBRAL CORTEX; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EDEMA; GUANOSINE; INJECTIONS, INTRAPERITONEAL; LETHAL DOSE 50; MALE; MICE; MOTOR ACTIVITY; PAIN; PAIN THRESHOLD; SPINAL CORD;

EID: 77949392485     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2009.00597.x     Document Type: Article

References (75)

1. Abacioglu N, Tunçtan B, Cakici I, Akbulut E, Uludag? O, Kanzik I (2001). The role of L-arginine/nitric oxide pathway in the antinociceptive activity of pyridoxine in mouse. Arzneimittelforschung 51: 832-838.
2. Alexander SP, Mathie A, Peters JA (2008). Guide to Receptors and Channels (GRAC), 3rd edition. Br J Pharmacol 153: S1-S209.
3. Baron BM, Dudley MW, McCarty DR, Miller FP, Reynolds IJ, Schmidt CJ (1989). Guanine nucleotides are competitive inhibitors of N-Methyl-D-Aspartate at its receptor site both in vitro and in vivo. J Pharmacol Exp Ther 250: 162-169.
4. Bastia E, Varani K, Monopoli A, Bertorelli R (2002). Effects of A(1) and A(2A) adenosine receptor ligands in mouse acute models of pain. Neurosci Lett 328: 241-244.
5. Beirith A, Santos ARS, Calixto JB (2002). Mechanisms underlying the nociception and paw oedema caused by injection of glutamate into the mouse paw. Brain Res 924: 219-228.
6. Boxall SJ, Berthele A, Tölle TR, Zieglgänsberger W, Urban L (1998). mGluR activation reveals a tonic NMDA component in inflammatory hyperalgesia. Neuroreport 9: 1201-1203.
7. Brambilla A, Prudentino A, Grippa N, Borsini F (1996). Pharmacological characterization of AMPA-induced biting behaviour in mice. Eur J Clin Pharmacol 305: 115-117.
8. Burgos JS, Barat A, Souza DO, Ramírez G (1998). Guanine nucleotides protect against kainate toxicity in an ex vivo chick retinal preparation. FEBS Lett 430: 176-180.
9. Burnstock G (2007). Physiology and pathophysiology of purinergic neurotransmission. Physiol Rev 87: 659-797.
10. Calcagnetti DJ, Fleetwood SW, Holtzman SG (1990). Pharmacological profile of the potentiation of opioid analgesia by restraint stress. Pharmacol Biochem Behav 37: 193-199.
11. Chang R, Algird A, Bau C, Rathbone MP, Jiang S (2008). Neuroprotective effects of guanosine on stroke models in vitro and in vivo. Neurosci Lett 431: 101-105.
12. Ciccarelli R, Di Iorio P, Giuliani P, D'Alimonte I, Ballerini P, Caciagli F et al. (1999). Rat cultured astrocytes release guanine-based purines in basal conditions and after hypoxia/hypoglycemia. Glia 25: 93-98.
13. Ciccarelli R, Ballerini P, Sabatino G, Rathbone MP, D'Onofrio M, Caciagli F et al. (2001). Involvement of astrocytes in purinemediated reparative processes in the brain. Int J Dev Neurosci 19: 395-414.
14. Creese I, Burt DR, Snyder SH (1976). DA receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192: 481-483.
15. Corrêa CR, Kyle DJ, Chakraverty S, Calixto JB (1996). Antinociceptive profile of the pseudopeptide B2 bradykinin receptor antagonist NPC 18688 in mice. Br J Clin Pharmacol 117: 552-558.
16. Costa-Campos L, Lara DR, Nunes DS, Elisabetsky E (1998). Antipsychotic-like profile of Alstonine. Pharmacol Biochem Behav 60: 133-141.
17. D'Amour FE, Smith DL (1941). A method for determining loss of pain sensation. J Pharmacol Exp Ther 72: 74-79.
18. Dall'Igna OP, Fett P, Gomes MW, Souza DO, Cunha RA, Lara DR (2007). Caffeine and adenosine A(2a) receptor antagonists prevent beta-amyloid(25-35)- induced cognitive deficits in mice. Exp Neurol 203: 241-245.
19. Dobolyi A, Reichart A, Szikra T, Nyitrai G, Kekesi KA, Juhasz G (2000). Sustained depolarisation induces changes in the extracellular concentrations of purine and pyrimidine nucleosides in the rat thalamus. Neurochem Int 37: 71-79.
20. Domanski L, Sulikowski T, Safranow K, Pawlik A, Olszewska M, Chlubek D et al. (2006). Effect of trimetazidine on the nucleotide profile in rat kidney with ischemia-reperfusion injury. Eur J Pharm Sci 27: 320-327.
21. Duarte ID, Ferreira SH (2000). L-NAME causes antinociception by stimulation of the arginine-NO-cGMP pathway. Mediators Inflamm 9: 25-30.
22. Eddy NB, Leimback D (1953). Synthetic analgesics II. Dithienylbutenyl and dithienylbutylamines. J Pharmacol Exp Ther 107: 385-393.
23. El Yacoubi M, Ledent C, Parmentier M, Costentin J, Vaugeois JM (2003). Caffeine reduces hypnotic effects of alcohol through adenosine A2A receptor blockade. Neuropharmacology 45: 977-985.
24. Frizzo MES, Lara DR, Dahm KCS, Prokopiuk AS, Swanson R, Souza DO (2001). Activation of glutamate uptake by guanosine in primary astrocyte cultures. Neuroreport 12: 879-881.
25. Frizzo MES, Lara DR, Prokopiuk AS, Vargas CR, Salbego CG, Wajner M et al. (2002). Guanosine enhances glutamate uptake in brain cortical slices at normal and excitotoxic conditions. Cell Mol Neurobiol 22: 353-363.
26. Frizzo MES, Soares FA, Dall'Onder LP, Lara DR, Swanson RA, Souza DO (2003). Extracellular conversion of guanine-based purines to guanosine specifically enhances astrocyte glutamate uptake. Brain Res 972: 84-89.
27. Gysbers JW, Rathbone MP (1996). Neurite outgrowth in PC12 cells is enhanced by guanosine through both cAMP-dependent and -independent mechanisms. Neurosci Lett 220: 175-178.
28. Hunskaar S, Hole K (1987). The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain 30: 103-114.
29. Inoue K, Tsuda M, Koizumi S (2005). ATP receptors in pain sensation: involvement of spinal microglia and P2X(4) receptors. Purinergic Signal 1: 95-100.
30. Jeftinija S, Jeftinija K, Liu F, Skilling SR, Smullin DH, Larson AA (1991). Excitatory amino acids are released from rat primary afferent neurons in vitro. Neurosci Lett 125: 191-194.
31. Jiang S, Khan MI, Lu Y, Wang J, Buttigieg J, Werstiuk ES et al. (2003). Guanosine promotes myelination and functional recovery in chronic spinal injury. Neuroreport 14: 2463-2467.
32. Jiang S, Ballerini P, D'Alimonte I, Nargi E, Jiang C, Huang X et al. (2007). Guanosine reduces apoptosis and inflammation associated with restoration of function in rats with acute spinal cord injury. Purinergic Signal 3: 411-421.
33. Jiang S, Fischione G, Guiliani P, Romano S, Caciagli F, Diiorio P (2008). Metabolism and distribution of guanosine given intraperitoneally: implications for spinal cord injury. Nucleosides Nucleotides Nucl Acids 27: 673-680.
34. Jurkowitz MS, Litsky ML, Browning MJ, Hohl CM (1998). Adenosine, inosine, and guanosine protect glial cells during glucose deprivation and mitochondrial inhibition: correlation between protection and ATP preservation. J Neurochem 71: 535-548.
35. Lara DR, Schmidt AP, Frizzo MES, Burgos JS, Ramirez G, Souza DO (2001). Effect of orally administered guanosine on seizures and death induced by glutamatergic agents. Brain Res 912: 176-180.
36. Le Bars D, Gozariu M, Cadden SW (2001). Animal models of nociception. Pharmacol Rev 53: 597-652.
37. Ledent C, Vaugeois JM, Schiffmann SN, Pedrazzini T, El Yacoubi M, Vanderhaeghen JJ et al. (1997). Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature 388: 674-678.
38. Litsky ML, Hohl CM, Lucas JH, Jurkowitz MS (1999). Inosine and guanosine preserve neuronal and glial cell viability in mouse spinal cord cultures during hypoxia. Brain Res 821: 426-432.
39. McGaraughty S, Jarvis MF (2005). Antinociceptive properties of a non-nucleotide P2X3/P2X2/3 receptor antagonist. Drug News Perspect 18: 501-507.
40. Malcon C, Achaval M, Komlos F, Partata W, Sauressig M, Ramírez G et al. (1997). GMP protects against quinolinic acid-induced loss of NADPH-diaphorase-positive cells in the rat striatum. Neurosci Lett 225: 145-148.
41. Millan MJ (1999). The induction of pain: an integrative review. Prog Neurobiol 57: 1-164.
42. Peterson GL (1977). A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 83: 346-356.
43. Poon A, Sawynok J (1998). Antinociception by adenosine analogs and inhibitors of adenosine metabolism in an inflammatory thermal hyperalgesia model in the rat. Pain 74: 235-245.
44. Rathbone M, Pilutti L, Caciagli F, Jiang S (2008). Neurotrophic effects of extracellular guanosine. Nucleosides Nucleotides Nucl Acids 27: 666-672.
45. Reeve AJ, Dickenson AH (1995). The roles of spinal adenosine receptors in the control of acute and more persistent nociceptive responses of dorsal horn neurones in the anaesthetized rat. Br J Pharmacol 116: 2221-2228.
46. Regner A, Ramírez G, Belló-Klein A, Souza DO (1998). Effects of guanine nucleotides on glutamate-induced chemiluminescence in rat hippocampal slices submitted to hypoxia. Neurochem Res 23: 519-524.
47. Roesler R, Vianna MR, Lara DR, Izquierdo I, Schmidt AP, Souza DO (2000). Guanosine impairs inhibitory avoidance performance in rats. Neuroreport 11: 2537-2540.
48. Sakurada T, Manome Y, Tan-No K, Sakurada S, Kisara K (1990). The effects of substance P analogues on the scratching, biting and licking response induced by intrathecal injection of N-methyl-Daspartate in mice. Br J Clin Pharmacol 101: 307-310.
49. Sakurada T, Katsumata K, Yogo H, Tan-No K, Sakurada S, Kisara K (1993). Antinociception induced by CP 96345, a non-peptide NK-1 receptor antagonist, in the formalin and capsaicin tests. Neurosci Lett 151: 142-145.
50. Sakurada T, Sugiyama A, Sakurada C, Tanno K, Sakurada S, Kisara K et al. (1996). Involvement of nitric oxide in spinally mediated capsaicin- and glutamate-induced behavioural responses in the mouse. Neurochem Int 29: 271-278.
51. Sakurada T, Wako K, Sugiyama A, Sakurada C, Tan-No K, Kisara K (1998). Involvement of spinal NMDA receptors in capsaicininduced nociception. Pharmacol Biochem Behav 59: 339-345.
52. Saute JA, da Silveira LE, Soares FA, Martini LH, Souza DO, Ganzella M (2006). Amnesic effect of GMP depends on its conversion to guanosine. Neurobiol Learn Mem 85: 206-212.
53. Sawynok J (1998). Adenosine receptor activation and nociception. Eur J Clin Pharmacol 317: 1-11.
54. Sawynok J, Liu XJ (2003). Adenosine in the spinal cord and periphery: release and regulation of pain. Prog Neurobiol 69: 313-340.
55. Schmidt AP, Lara DR, Maraschin JF, Perla AS, Souza DO (2000). Guanosine and GMP prevent seizures induced by quinolinic acid in mice. Brain Res 864: 40-43.
56. Schmidt AP, Ávila TT, Souza DO (2005). Intracerebroventricular guanine-based purines protect against seizures induced by quinolinic acid in mice. Neurochem Res 30: 69-73.
57. Schmidt AP, Lara DR, Souza DO (2007). Proposal of a guanine-based purinergic system in the mammalian central nervous system. Pharmacol Ther 116: 401-416.
58. Schmidt AP, Böhmer AE, Leke R, Schallenberger C, Antunes C, Pereira MS et al. (2008). Antinociceptive effects of intracerebroventricular administration of guanine-based purines in mice: evidences for the mechanism of action. Brain Res 1234: 50-58.
59. Schmidt AP, Böhmer AE, Antunes C, Schallenberger C, Porciúncula LO, Elisabetsky E et al. (2009a). Anti-nociceptive properties of the xanthine oxidase inhibitor allopurinol in mice: role of A1 adenosine receptors. Br J Pharmacol 156: 163-172.
60. Schmidt AP, Böhmer AE, Schallenberger C, Antunes C, Pereira MS, Leke R et al. (2009b). Spinal mechanisms of antinociceptive action caused by guanosine in mice. Eur J Pharmacol 613: 46-53.
61. Schulte G, Robertson B, Fredholm BB, DeLander GE, Shortland P, Molander C (2003). Distribution of antinociceptive adenosine A1 receptors in the spinal cord dorsal horn, and relationship to primary afferents and neuronal subpopulations. Neuroscience 121: 907-916.
62. Soares FA, Schmidt AP, Farina M, Frizzo ME, Tavares RG, Portela LV et al. (2004). Anticonvulsant effect of GMP depends on its conversion to guanosine. Brain Res 1005: 182-186.
63. Souza DO, Ramirez G (1991). Effects of guanine nucleotides on KA binding and on adenylate cyclase activity in optic tectum and cerebellum of chicken. J Mol Neurosci 3: 39-46.
64. Sorkin LS, McAdoo DJ (1993). Amino acids and serotonin are released into the lumbar spinal cord of the anesthetized cat following intradermal capsaicin injections. Brain Res 607: 89-98.
65. Traversa U, Bombi G, Camaioni E, Macchiarulo A, Costantino G, Palmieri C et al. (2003). Rat brain guanosine binding site. Biological studies and pseudo-receptor construction. Bioorg Med Chem 11: 5417-5425.
66. Traversa U, Bombi G, Di Iorio P, Ciccarelli R, Werstiuk ES, Rathbone MP (2002). Specific [3H]-guanosine binding sites in rat brain membranes. Br J Pharmacol 135: 969-976.
67. Tomaselli B, Podhraski V, Heftberger V, Bock G, Baier-Bitterlich G (2005). Purine nucleoside-mediated protection of chemical hypoxia-induced neuronal injuries involves p42/44 activation. Neurochem Int 46: 513-521.
68. Ueda M, Kuraishi Y, Satoh M (1993). Detection of capsaicin-evoked release of glutamate from spinal dorsal horn slices of rat with on-line monitoring system. Neurosci Lett 155: 179-182.
69. Urca G, Raigorodsky G (1988). Behavioral classification of excitatory amino acid receptors in mouse spinal cord. Eur J Pharmacol 153: 211-220.
70. Vinadé ER, Izquierdo I, Lara DR, Schmidt AP, Souza DO (2004). Oral administration of guanosine impairs inhibitory avoidance performance in rats and mice. Neurobiol Learn Mem 81: 137-143.
71. Vinadé ER, Schmidt AP, Frizzo MES, Izquierdo I, Elizabetsky E, Souza DO (2003). Chronically administered guanosine is anticonvulsant, amnesic and anxiolytic in mice. Brain Res 977: 97-102.
72. Vinadé ER, Schmidt AP, Frizzo MES, Portela LV, Soares FA, Schwalm FD et al. (2005). Effects of chronic administered guanosine on behavioral parameters and brain glutamate uptake in rats. J Neurosci Res 79: 248-253.
73. Yoon MH, Bae HB, Choi JI (2005). Antinociception of intrathecal adenosine receptor subtype agonists in rat formalin test. Anesth Analg 101: 1417-1421.
74. Zahn PK, Straub H, Wenk M, Pogatzki-Zahn E (2007). Adenosine A1 but not A2a receptor agonist reduces hyperalgesia caused by a surgical incision in rats. Anesthesiology 107: 797-806.
75. Zimmermann M (1983). Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16: 109-110.